Isolation, chemical characterization, and quantitation of Aβ 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits

Yu Min Kuo, Mark R. Emmerling, Amina S. Woods, Robert J. Cotter, Alex E. Roher

Research output: Contribution to journalArticle

Abstract

From the neuritic plaques and vascular walls of the brains of patients with Alzheimer disease, we have purified and quantified an Aβ peptide which starts at residue 3Glu in the form of pyroglutamyl (Aβ3pE). The N-terminally truncated Aβ3pE comprised 51% of the Aβ in the neuritic plaques. This was followed by 30% starting at position 1Asp which included 20% in the isomerized form (IsoAsp). In contrast, the vascular amyloid only contained an average of 11% in the form of Aβ3pE with the major component starting at residue 1Asp (69%), which included only 6% in the form of IsoAsp. The presence of Aβ3pE has important structural consequences since it is more hydrophobic than other forms of Aβ, thus increasing the insolubility of Aβ. In addition, Aβ3pE, with its blocked N-terminus to the action of common aminopeptidases, may result in the profuse accumulation of Aβ in the neuritic plaques of Alzheimer disease.

Original languageEnglish (US)
Pages (from-to)188-191
Number of pages4
JournalBiochemical and Biophysical Research Communications
Volume237
Issue number1
DOIs
StatePublished - Aug 8 1997

Fingerprint

Amyloid Plaques
Amyloid
Blood Vessels
Deposits
Peptides
Aminopeptidases
Alzheimer Disease
Brain
Solubility

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Isolation, chemical characterization, and quantitation of Aβ 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits. / Kuo, Yu Min; Emmerling, Mark R.; Woods, Amina S.; Cotter, Robert J.; Roher, Alex E.

In: Biochemical and Biophysical Research Communications, Vol. 237, No. 1, 08.08.1997, p. 188-191.

Research output: Contribution to journalArticle

@article{6ec1a89971da40f78f2661f1527ef053,
title = "Isolation, chemical characterization, and quantitation of Aβ 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits",
abstract = "From the neuritic plaques and vascular walls of the brains of patients with Alzheimer disease, we have purified and quantified an Aβ peptide which starts at residue 3Glu in the form of pyroglutamyl (Aβ3pE). The N-terminally truncated Aβ3pE comprised 51{\%} of the Aβ in the neuritic plaques. This was followed by 30{\%} starting at position 1Asp which included 20{\%} in the isomerized form (IsoAsp). In contrast, the vascular amyloid only contained an average of 11{\%} in the form of Aβ3pE with the major component starting at residue 1Asp (69{\%}), which included only 6{\%} in the form of IsoAsp. The presence of Aβ3pE has important structural consequences since it is more hydrophobic than other forms of Aβ, thus increasing the insolubility of Aβ. In addition, Aβ3pE, with its blocked N-terminus to the action of common aminopeptidases, may result in the profuse accumulation of Aβ in the neuritic plaques of Alzheimer disease.",
author = "Kuo, {Yu Min} and Emmerling, {Mark R.} and Woods, {Amina S.} and Cotter, {Robert J.} and Roher, {Alex E.}",
year = "1997",
month = "8",
day = "8",
doi = "10.1006/bbrc.1997.7083",
language = "English (US)",
volume = "237",
pages = "188--191",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Isolation, chemical characterization, and quantitation of Aβ 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits

AU - Kuo, Yu Min

AU - Emmerling, Mark R.

AU - Woods, Amina S.

AU - Cotter, Robert J.

AU - Roher, Alex E.

PY - 1997/8/8

Y1 - 1997/8/8

N2 - From the neuritic plaques and vascular walls of the brains of patients with Alzheimer disease, we have purified and quantified an Aβ peptide which starts at residue 3Glu in the form of pyroglutamyl (Aβ3pE). The N-terminally truncated Aβ3pE comprised 51% of the Aβ in the neuritic plaques. This was followed by 30% starting at position 1Asp which included 20% in the isomerized form (IsoAsp). In contrast, the vascular amyloid only contained an average of 11% in the form of Aβ3pE with the major component starting at residue 1Asp (69%), which included only 6% in the form of IsoAsp. The presence of Aβ3pE has important structural consequences since it is more hydrophobic than other forms of Aβ, thus increasing the insolubility of Aβ. In addition, Aβ3pE, with its blocked N-terminus to the action of common aminopeptidases, may result in the profuse accumulation of Aβ in the neuritic plaques of Alzheimer disease.

AB - From the neuritic plaques and vascular walls of the brains of patients with Alzheimer disease, we have purified and quantified an Aβ peptide which starts at residue 3Glu in the form of pyroglutamyl (Aβ3pE). The N-terminally truncated Aβ3pE comprised 51% of the Aβ in the neuritic plaques. This was followed by 30% starting at position 1Asp which included 20% in the isomerized form (IsoAsp). In contrast, the vascular amyloid only contained an average of 11% in the form of Aβ3pE with the major component starting at residue 1Asp (69%), which included only 6% in the form of IsoAsp. The presence of Aβ3pE has important structural consequences since it is more hydrophobic than other forms of Aβ, thus increasing the insolubility of Aβ. In addition, Aβ3pE, with its blocked N-terminus to the action of common aminopeptidases, may result in the profuse accumulation of Aβ in the neuritic plaques of Alzheimer disease.

UR - http://www.scopus.com/inward/record.url?scp=0031559602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031559602&partnerID=8YFLogxK

U2 - 10.1006/bbrc.1997.7083

DO - 10.1006/bbrc.1997.7083

M3 - Article

C2 - 9266855

AN - SCOPUS:0031559602

VL - 237

SP - 188

EP - 191

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -